Drug Control Authority Statement on Cardiac Safety of Rosiglitazone (Avandia)

User Rating: 1 / 5

Star ActiveStar InactiveStar InactiveStar InactiveStar Inactive

Date : 07 July 2007

Description : Kenyataan Pihak Berkuasa Kawalan Dadah berhubung dengan keselamatan kardiak dengan penggunaan ubat rosiglitazone (Avandia)


Click here to download (22KB icon pdf)

National Pharmaceutical Regulatory Agency (NPRA)

Lot 36, Jalan Universiti (Jalan Profesor Diraja Ungku Aziz), 46200 Petaling Jaya, Selangor, Malaysia.

  • Email: npra@npra.gov.my
  • Phone: +603-7883 5400
  • Fax: +603-7956 2924, +603-7956 7075



Image   Image   Image   Image  


The Government of Malaysia and the National Pharmaceutical Regulatory Agency are not responsible for any loss or damage caused by the usage of any information obtained from this website.

Mobile Web :

Site Last Modified

  • Last Modified: Thursday 01 December 2022, 08:13:38.
© Copyright 2022 . All Rights Reserved National Pharmaceutical Regulatory Agency NPRA